Status:
UNKNOWN
Evaluation of the Impact of an Oral and Practical Presentation of Intrauterine Devices by a Health Professional on Women's Opinion as a Possible Contraceptive Method
Lead Sponsor:
Raincy Montfermeil Hospital Group
Conditions:
Acceptance Processes
Eligibility:
FEMALE
18-45 years
Phase:
NA
Brief Summary
Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns...
Detailed Description
Contraception among women in France has evolved considerably and has become a frequent reason for consultation in general practice in view of the growing shortage of gynaecologists practising in towns...
Eligibility Criteria
Inclusion
- Any woman aged 18 years and over who comes to a family planning centre
- Having expressed her free and informed written consent
- Affiliated to a social security scheme
Exclusion
- Women under 18 years of age
- Woman with an IUD
- Woman who has had an IUD before
- Woman whose reason for consultation of the day is the insertion of an IUD
- Menopausal woman
- Woman who is infertile for any reason
- Illiterate woman or woman who does not read French
- Refusal to participate in the protocol
- Incapable of age.
- Pregnant or breastfeeding women
- Vulnerable persons and protected persons as provided for in the Public Health Code Public Health Code (articles L. 1121-5 to L.1121-8 and L.1122-1-2).
Key Trial Info
Start Date :
April 14 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
October 1 2022
Estimated Enrollment :
160 Patients enrolled
Trial Details
Trial ID
NCT05317715
Start Date
April 14 2022
End Date
October 1 2022
Last Update
May 2 2022
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Le Raincy Montfermeil hospital
Montfermeil, France, 93370